Table 1.
Overall (N = 81,180) | Patients Admitted for HF (N = 11563) | HF Admission ≤3 months† (N = 6,252) | HF Admission >3 months† (N = 63,365) | |
---|---|---|---|---|
Demographics* | ||||
Age - Mean (SD) | 73 (8) | 73 (9) | 74 (8) | 73 (8) |
Sex: Female | 28 | 29 | 32 | 27 |
Race | ||||
White non-Hispanic | 83 | 75 | 78 | 85 |
Black non-Hispanic | 11 | 16 | 15 | 9 |
Hispanic | 4 | 6 | 5 | 4 |
Other | 2 | 2 | 2 | 2 |
Clinical Characteristics | ||||
NICM | 38 | 40 | 39 | 38 |
LVEF, Mean (SD) | 26 (6) | 23 (7) | 24 (7) | 26 (6) |
NYHA Class | ||||
I | 2 | 1 | 1 | 3 |
II | 31 | 15 | 21 | 36 |
III | 63 | 74 | 73 | 60 |
IV | 3 | 11 | 5 | 2 |
Atrial fibrillation/flutter | 40 | 48 | 44 | 38 |
Cerebrovascular Disease | 17 | 20 | 19 | 17 |
Currently on Dialysis | 3 | 4 | 4 | 3 |
Diabetes | 42 | 49 | 49 | 41 |
Chronic Lung Disease | 25 | 34 | 31 | 22 |
QRS Duration, Median (25th-75th) | 127 (103-154) | 130 (104-154) | 130 (104-156) | 126 (102-154) |
Left Bundle Branch Block | 35 | 34 | 36 | 35 |
BUN, Mean (SD) | 26 (14) | 32 (16) | 31 (15) | 25 (12) |
Sodium, Mean (SD) | 139 (3) | 138 (4) | 138 (4) | 139 (3) |
Hemoglobin, Mean (SD) | 13.0 (1.8) | 12.1 (1.9) | 12.5 (1.8) | 13.2 (1.7) |
Procedure | ||||
Implanted Device Type | ||||
Single Chamber | 19 | 16 | 17 | 19 |
Dual Chamber | 27 | 25 | 22 | 27 |
CRT-D | 55 | 59 | 60 | 53 |
Discharge Medications | ||||
ACEI | 58 | 55 | 55 | 59 |
ARB | 21 | 17 | 20 | 22 |
Beta-Blockers | 91 | 89 | 90 | 91 |
Hydralazine | 5 | 10 | 9 | 4 |
Long Acting Nitroglycerin | 13 | 17 | 17 | 12 |
Digoxin | 18 | 24 | 22 | 17 |
Diuretics | 71 | 81 | 86 | 68 |
Aspirin | 71 | 70 | 70 | 72 |
Statins | 70 | 66 | 67 | 71 |
Non-Statin | 11 | 8 | 10 | 12 |
Antiarrhythmic Agents | 13 | 18 | 16 | 11 |
Channel Blockers | 9 | 8 | 9 | 9 |
Warfarin | 30 | 34 | 32 | 29 |
Thienopyridines | 24 | 22 | 24 | 24 |
all numbers are calculated using complete cases within each variable
3 months defined as 90 days
Abbreviations: ICD = implantable cardioverter-defibrillation; HF = heart failure; SD = standard deviation; NICM = nonischemic cardiomyopathy; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association; CRT-D = cardiac resynchronization therapy-defibrillator; ACEI = angiotensin converting-enzyme inhibitor; angiotensin receptor blocker.